SVF is developing a novel platform for vaccines and imunnetherapies that could be administrated as DNA, proteinbased or RNA.
Our first candidates targets disease areas with a high unmet medical need Hepatitis B(HBV), Hepatitis D(HDV) and corona viruses with targeted indications:
HDV therapeutic vaccine
HDV prophylactic vaccine
HBV therapeutic vaccine
Corona viruss prophylactic vaccine
HDV: Aprox 12M carriers worldwide and increasing prevalence in the EU, 3-5% prevalence among HBV carriers and >15% in HBV patients visiting specialist clinics. Main course to cirrhosis and liver cancer. No preventive vaccine available and very limited treatment options. Potential as Orphan drug and fast track designation. Significant commercial potenital
HBV: Huge population (300M), even small at-high-risk segments have significant commercial potential. Targeting patients already under care on existing treatments. Untreated HBV causes cirrhosis and liver cancer with high costs for patients as well as health care
coronavirus: ongoing pandemic with a high unmet need. SVF strategy is to make the vaccine future proof towards other coronaviruses than Sars-Cov2
SVF has experienced expertise of top researchers on viral hepatitis vaccines and immunotherapies and a strong track record of launching several” first in class” drugs at big pharma companies in its team.
If you have any questions, please contact us:
Jens Bäck
Mail: jens@vaccinfabriken.se
cell:+46730852339
Company Details
- Employees
- 6
- Founded
- -
- Address
- Hälsingegatan, Stockholm,stockholm 11010,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- vaccinfabriken.se
- Keywords
- Hepatitis D, Hepatitis B, Vaccines, Pharmaceuticals, Research, Marketing, Sales, Immunotherapy, covid-19.
- HQ
- Stockholm, Stockholm
Svf Vaccines Ab Questions
Svf Vaccines Ab's website is vaccinfabriken.se
Svf Vaccines Ab's LinkedIn profile is https://se.linkedin.com/company/svf-vaccines-ab
Svf Vaccines Ab has
6 employees.
View email and phone details for 6
employees at Svf Vaccines Ab.
Svf Vaccines Ab's industry is
Biotechnology Research
Svf Vaccines Ab's top competitors are
Northx Biologics,
Isv Annual Congress,
International Society For Vaccines - Isv,
Stirx Inc,
Vaccines R&d,
Opencorona,
Sulis Therapeutics,
Frelin Consulting Ab,
Skatteforsk - Centre For Tax Research,
Sirlin Lesser & Benson.
Svf Vaccines Ab's categories are Biotechnology Research
Svf Vaccines Ab's founding year is 2015
